Page last updated: 2024-08-23

mifepristone and Hemorrhage, Uterine

mifepristone has been researched along with Hemorrhage, Uterine in 93 studies

Research

Studies (93)

TimeframeStudies, this research(%)All Research%
pre-19909 (9.68)18.7374
1990's26 (27.96)18.2507
2000's33 (35.48)29.6817
2010's17 (18.28)24.3611
2020's8 (8.60)2.80

Authors

AuthorsStudies
Enzelsberger, SH; Hermann, P; Oppelt, P; Shebl, O; Trautner, PS; Wagner, H; Wetzlmair, D1
Braat, DDM; Coppus, SFPJ; Hamel, CC; Snijders, MPLM; Vandenbussche, FPHA; Vart, P1
Guowen, LI; Huifeng, W; Jie, LI; Lijun, YU; Tiantian, Z; Yuan, G; Zhifeng, C1
Huang, Q; Li, LL; Peng, DY; Qi, JJ; Yao, M1
Chen, MJ; Creinin, MD; Dalton, L; Hou, MY; Steward, R1
Atrio, JM; Creinin, MD; Koelper, N; McAllister, A; Sammel, MD; Schreiber, CA; Sonalkar, S1
Mihalceanu, E; Onofriescu, M; Pintilie, R; Pristavu, A; Socolov, D; Vinturache, A1
Aronowitz, SV1
Heikinheimo, O; Korjamo, R; Mentula, M1
Bouchard, P; Chabbert-Buffet, N; Daraï, E; Kolanska, K1
Aabø, RS; Iversen, OE; Janbu, T; Løkeland, M; Pay, ASD; Økland, I1
Kovač, V; Reljič, M; Serdinšek, T1
Chen, J; Guo, Q; Huang, B; Qiu, L; Ren, Z; Wan, R; Wang, M; Wang, X; Wang, Y; Ying, J; Yu, H; Yu, J1
Guo, Y; Jiang, G; Li, X; Li, Y; Wang, B; Wang, L; Yao, C; Zhang, M; Zhao, X; Zhou, X1
Bjørge, L; Engeland, A; Iversen, OE; Løkeland, M; Økland, I1
Cui, J; Cui, W; Shao, X; Wen, P1
Friedlander, E; Kaneshiro, B1
Frank, K; Gerychová, R; Huser, M; Janků, P; Ventruba, P1
Bouchard, P; Chabbert-Buffet, N; Kairis, AP; Ouzounian, S1
Huang, L; Li, L; Zhou, Z1
Findlay, JK; Fraser, IS; Hickey, M; O'Connor, V; Palmer, D; Salamonsen, LA; Weisberg, E1
Engman, M; Gemzell-Danielsson, K; Granberg, S; Lalitkumar, PG; Meng, CX; Williams, AR1
Bonfiglio, T; Eisinger, SH; Fiscella, J; Fiscella, K; Meldrum, S1
Chi, X; Guo, Y; Jiang, G; Li, X; Liu, R; Ma, R; Wang, B; Wang, L; Yao, C; Zhang, W; Zhou, X1
Achilles, SL; Creinin, MD; Hayes, JL; Reeves, MF1
Chen, FH; Li, CW; Li, JP; Li, X; Lu, WG; Yuan, FL; Zhao, YQ1
Burger, HG; Croxatto, HB; Findlay, JK; Fraser, IS; Weisberg, E1
Chen, AM; Cheng, YM; Gao, ES; Liang, H; Luo, L; Yuan, W1
Guo, Y; Jiang, G; Li, X; Li, Y; Wang, B; Wang, L; Yao, C; Zhao, X; Zhou, X1
Chen, DJ; Du, PL; Li, CL; Liu, MX; Liu, Q; Sheng, XJ; Wei, M; Weng, HN1
Ho, PC; Lee, SW; Tang, OS1
Fielding, SL; Schaff, EA; Westhoff, C1
Baird, DT; Critchley, HO; Hapangama, DK; Henderson, TA1
Ma, DM; Sun, HL; Yang, ML1
Dai, M; Liu, Q; Peng, D; Zi, X1
Hausknecht, R1
Felix, JC; Jain, JK; Kuo, J; Lu, JJ; Nicosia, AF; Nucatola, DL1
Croxatto, HB; d'Arcangues, C; Fuentealba, B; Massai, MR; Pavez, M1
Hu, CF; Long, X; Wu, KM; Zeng, J; Zeng, N; Zhang, LM1
Hwang, AC; Stewart, FH; Taylor, D1
Chien, P; Guest, J; Kosseim, ML; Thomson, M1
Arvidsson, C; Gemzell-Danielsson, K; Hellborg, M1
Borgatta, L; Chen, AY; Mottl-Santiago, J; Vragovic, O; Wasserman, S1
Dunn, S; Guilbert, E; Jacot, F; Shannon, C; Sheldon, WR; Wiebe, E; Winikoff, B1
Baird, D; von Hertzen, H1
Sitruk-Ware, R1
Cheng, L1
Fiala, C; Gemzel-Danielsson, K1
Dempsey-Fanning, A; Teal, SB; Westhoff, C1
Felix, JC; Jain, JK; Li, A; Minoo, P; Xiong, DW; Yang, W1
Cheng, LN; Du, MK; Lu, YL; Sang, GW; Shao, QX; Weng, LJ; Wu, XZ1
Cen, HX; Jin, YC; Xu, MF1
Peplow, PV1
Silvestre, L; Ulmann, A1
Chan, YF; Ho, PC; Ma, HK1
Baton-Saint-Mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C1
Choolani, M; Prasad, RN; Ratnam, SS; Roy, A1
Aubény, E; Baulieu, EE; Peyron, R; Renault, M; Silvestre, L; Targosz, V; Turpin, CL; Ulmann, A1
Ho, PC; Lao, T; Ngai, SW; Yeung, KC1
Eisinger, SH; Franks, P; Schaff, EA; Stadalius, LS1
Pan, J; Sun, L1
Bardin, CW; Benton, L; Robbins, A; Spitz, IM1
El-Refaey, H; Templeton, A1
Ashok, PW; Flett, GM; Templeton, A1
Baird, DT; Brown, AH; Martin, CW1
Coyaji, K; Ellertson, C; Harper, C; Winikoff, B1
Cheng, L; Gao, PP; Ho, PC; Lee, SW; Tang, OS1
Dai, DY; Wu, DX; Zhang, TT1
Brooks, L; Grinsted, J; Grinsted, L; Jacobsen, JD; Nielsen, SP; Sandstrøm, O; Schantz, A1
Davis, A; De Nonno, L; Westhoff, C1
Chen, J; Cheng, L; Glasier, A; Ren, F; Wang, A; Zhu, H1
De Nonno, LJ; Fielding, S; Schaff, E; Westhoff, C1
Li, D; Qiu, X; Zhou, X1
Cheng, L; Tong, C; Xiao, Z1
Ashok, PW; Narvekar, N; Smith, NC; Templeton, A; Wagaarachchi, PT1
Cheng, L; Ho, PC; Lee, SW; Tang, OS; Xu, J1
Wang, Z1
Critchley, HO; Davie, JE; Glasier, AF; Kelly, RW; Wang, H1
Weimin, W; Wenqing, L1
Berer, M1
Aubeny, E1
Elie, R; Lanza, E; Lefebvre, Y; Poulin, O; Proulx, L1
Baulieu, EE; Dubois, C; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A1
Philibert, D; Teutsch, G; Ulmann, A1
Schaison, G1
Grimes, DA; Lacarra, M; Mishell, DR; Shoupe, D1
Baird, DT; Rodger, MW1
Carol, W; Klinger, G1
Croxatto, HB; Croxatto, HD; Salvatierra, AM; Spitz, IM1
Kerrigan, P1
Chaneac, M; Maria, B; Stampf, F; Ulmann, A1
Brenner, PF; Mishell, DR; Shoupe, D; Spitz, IM1
Baulieu, EE; Couzinet, B; Le Strat, N; Schaison, G; Ulmann, A1

Reviews

8 review(s) available for mifepristone and Hemorrhage, Uterine

ArticleYear
Selective progesterone receptor modulators: current applications and perspectives.
    Climacteric : the journal of the International Menopause Society, 2018, Volume: 21, Issue:4

    Topics: Abortion, Induced; Endometriosis; Female; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Pregnancy; Progesterone; Receptors, Progesterone; Uterine Hemorrhage; Uterine Neoplasms

2018
Therapeutic Options for Unscheduled Bleeding Associated with Long-Acting Reversible Contraception.
    Obstetrics and gynecology clinics of North America, 2015, Volume: 42, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraception; Doxycycline; Female; Hormone Antagonists; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Matrix Metalloproteinase Inhibitors; Mifepristone; Practice Guidelines as Topic; Time Factors; Tranexamic Acid; Uterine Hemorrhage

2015
Contraceptive applications of progesterone receptor modulators.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2008, Volume: 13, Issue:3

    Topics: Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Female; Humans; Mifepristone; Ovulation; Receptors, Progesterone; Uterine Hemorrhage

2008
Care for women choosing medication abortion.
    The Nurse practitioner, 2004, Volume: 29, Issue:10

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Decision Making; Female; Humans; Mifepristone; Patient Education as Topic; Pregnancy; Uterine Hemorrhage

2004
Mifepristone and misoprostol sequential regimen side effects, complications and safety.
    Contraception, 2006, Volume: 74, Issue:1

    Topics: Abortifacient Agents; Abortion, Induced; Animals; Clinical Trials as Topic; Female; Humans; Mifepristone; Misoprostol; Pelvic Infection; Pregnancy; Uterine Hemorrhage

2006
Medical abortion in early pregnancy: experience in China.
    Contraception, 2006, Volume: 74, Issue:1

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; China; Chorionic Gonadotropin; Dinoprost; Female; Gestational Age; History, 20th Century; Humans; Mifepristone; Pregnancy; Uterine Hemorrhage

2006
Review of medical abortion using mifepristone in combination with a prostaglandin analogue.
    Contraception, 2006, Volume: 74, Issue:1

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Sublingual; Analgesia, Obstetrical; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prostaglandins; Time Factors; Uterine Contraction; Uterine Hemorrhage; World Health Organization

2006
Effect of early pregnancy on a previous lower segment cesarean section scar.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2002, Volume: 77, Issue:3

    Topics: Adult; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Cicatrix; Female; Humans; Hysterectomy; Methotrexate; Mifepristone; Postoperative Complications; Pregnancy; Trichosanthin; Ultrasonography; Uterine Hemorrhage; Uterine Rupture

2002

Trials

47 trial(s) available for mifepristone and Hemorrhage, Uterine

ArticleYear
Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model.
    Human reproduction (Oxford, England), 2022, 05-03, Volume: 37, Issue:5

    Topics: Abortion, Spontaneous; Colic; Female; Humans; Male; Mifepristone; Models, Statistical; Pregnancy; Probability; Prognosis; Uterine Hemorrhage

2022
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.
    Obstetrics and gynecology, 2020, Volume: 135, Issue:1

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adult; California; Chorionic Gonadotropin; Double-Blind Method; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Progesterone; Uterine Hemorrhage; Vacuum Curettage; Young Adult

2020
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
    American journal of obstetrics and gynecology, 2020, Volume: 223, Issue:4

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Treatment Outcome; Uterine Hemorrhage

2020
Fast-track vs. delayed insertion of the levonorgestrel-releasing intrauterine system after early medical abortion - a randomized trial.
    Contraception, 2017, Volume: 96, Issue:5

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Feasibility Studies; Female; Finland; Follow-Up Studies; Humans; Intention to Treat Analysis; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Mifepristone; Misoprostol; Patient Dropouts; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Time Factors; Uterine Hemorrhage; Young Adult

2017
Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.
    Journal of ethnopharmacology, 2013, Dec-12, Volume: 150, Issue:3

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Cytokines; Decidua; Drugs, Chinese Herbal; Female; Forkhead Transcription Factors; GATA3 Transcription Factor; Humans; Mifepristone; Nuclear Receptor Subfamily 1, Group F, Member 3; Pregnancy; T-Box Domain Proteins; T-Lymphocyte Subsets; T-Lymphocytes; Uterine Hemorrhage; Young Adult

2013
Application prospect and clinical effect analysis of Fu Chan Xue Jing during bleeding after abortion.
    Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:5 Suppl

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drugs, Chinese Herbal; Female; Humans; Menstruation; Mifepristone; Postoperative Hemorrhage; Pregnancy; Uterine Hemorrhage; Young Adult

2015
A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users.
    Human reproduction (Oxford, England), 2009, Volume: 24, Issue:8

    Topics: Adult; Contraceptive Agents, Female; Desogestrel; Doxycycline; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Mifepristone; Uterine Hemorrhage

2009
Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial.
    Human reproduction (Oxford, England), 2009, Volume: 24, Issue:8

    Topics: Adult; Double-Blind Method; Female; Hemoglobins; Humans; Leiomyoma; Middle Aged; Mifepristone; Regional Blood Flow; Uterine Hemorrhage; Uterine Neoplasms; Uterus

2009
Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata.
    European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 146, Issue:2

    Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Female; Health Status; Hormone Antagonists; Humans; Leiomyoma; Middle Aged; Mifepristone; Pain; Quality of Life; Uterine Hemorrhage; Uterine Neoplasms

2009
Up-regulation of Fas/FasL activation contribute to the apoptosis enhancement of RU486 by Gong-Qing Decoction, a traditional Chinese prescription.
    Journal of ethnopharmacology, 2011, Mar-24, Volume: 134, Issue:2

    Topics: Abortion, Induced; Adult; Apoptosis; Caspase 3; Caspase 8; Drug Therapy, Combination; Drugs, Chinese Herbal; Fas Ligand Protein; Female; Humans; Mifepristone; Phytotherapy; Pregnancy; Up-Regulation; Uterine Hemorrhage; Uterus; Vacuum Curettage; Young Adult

2011
A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.
    Contraception, 2011, Volume: 84, Issue:6

    Topics: Adolescent; Adult; Cervix Mucus; Contraceptive Agents, Female; Desogestrel; Double-Blind Method; Drug Implants; Drug Interactions; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Luteinization; Menstrual Cycle; Middle Aged; Mifepristone; Ovary; Ovulation Inhibition; Ultrasonography; Uterine Hemorrhage; Viscosity; Young Adult

2011
[The lowest dosages of mifepristone and misoprostol to terminate ultra-early pregnancy].
    Zhonghua fu chan ke za zhi, 2012, Volume: 47, Issue:10

    Topics: Abdominal Pain; Abortifacient Agents; Abortion, Induced; Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Nausea; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage; Young Adult

2012
A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone.
    Human reproduction (Oxford, England), 2002, Volume: 17, Issue:11

    Topics: Abortifacient Agents, Steroidal; Adult; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Failure; Uterine Hemorrhage

2002
Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy.
    Contraception, 2002, Volume: 66, Issue:4

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Treatment Outcome; Uterine Hemorrhage

2002
[Clinical observation on effect of xuejie jiawei decoction on vaginal hemorrhagic amount and duration in patients after drug-abortion].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2001, Volume: 21, Issue:11

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Phytotherapy; Pregnancy; Uterine Hemorrhage

2001
Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate.
    Steroids, 2003, Volume: 68, Issue:10-13

    Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Endometrium; Estrogen Receptor alpha; Estrogens; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Mifepristone; Ovulation; Progesterone; Random Allocation; Receptors, Estrogen; Receptors, Progesterone; Time Factors; Uterine Hemorrhage

2003
Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users.
    Contraception, 2004, Volume: 70, Issue:1

    Topics: Administration, Oral; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levonorgestrel; Mifepristone; Pregnancy; Prospective Studies; Treatment Outcome; Uterine Hemorrhage

2004
Randomised controlled trial comparing efficacy of same day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36- to 48-hour protocol.
    BJOG : an international journal of obstetrics and gynaecology, 2005, Volume: 112, Issue:10

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Clinical Protocols; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage

2005
Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Nov-01, Volume: 123, Issue:1

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Oral; Administration, Topical; Analgesics; Female; Humans; Mifepristone; Misoprostol; Nausea; Pain; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Uterine Hemorrhage; Vagina; Vomiting

2005
Bleeding after medication-induced termination of pregnancy with two dosing schedules of mifepristone and misoprostol.
    Contraception, 2006, Volume: 73, Issue:4

    Topics: Abortifacient Agents; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Time Factors; Uterine Hemorrhage

2006
Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial.
    BJOG : an international journal of obstetrics and gynaecology, 2006, Volume: 113, Issue:6

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Treatment Outcome; Uterine Hemorrhage

2006
Predictors of acceptability of medication abortion.
    Contraception, 2007, Volume: 75, Issue:3

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Parity; Patient Acceptance of Health Care; Pregnancy; Treatment Failure; Uterine Hemorrhage

2007
Effect of mifepristone on endometrial matrix metalloproteinase expression and leukocyte abundance in new medroxyprogesterone acetate users.
    Contraception, 2007, Volume: 76, Issue:1

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; DNA Primers; Double-Blind Method; Endometrium; Female; Humans; Immunohistochemistry; Leukocytes; Matrix Metalloproteinases; Medroxyprogesterone Acetate; Middle Aged; Mifepristone; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome; Uterine Hemorrhage

2007
Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05--a multicentre randomized clinical trial in China.
    Contraception, 1994, Volume: 50, Issue:6

    Topics: Abdominal Pain; Abortion, Induced; Administration, Oral; Adolescent; Adult; China; Diarrhea; Dinoprost; Dose-Response Relationship, Drug; Female; Humans; Mifepristone; Misoprostol; Pessaries; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage

1994
RU486: the French experience.
    Human reproduction (Oxford, England), 1994, Volume: 9 Suppl 1

    Topics: Abdominal Pain; Abortion, Induced; Adult; Alprostadil; Contraindications; Dinoprostone; Female; France; Humans; Hypotension; Mifepristone; Misoprostol; Myocardial Infarction; Pilot Projects; Pregnancy; Uterine Hemorrhage

1994
Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost.
    Contraception, 1993, Volume: 47, Issue:1

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Alprostadil; Dose-Response Relationship, Drug; Female; Hemoglobins; Humans; Mifepristone; Pregnancy; Suction; Uterine Hemorrhage

1993
Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial.
    Human reproduction (Oxford, England), 1993, Volume: 8, Issue:3

    Topics: Abortion, Missed; Adult; Double-Blind Method; Female; Humans; Mifepristone; Placebos; Pregnancy; Prospective Studies; Uterine Hemorrhage

1993
Blood loss in termination of early pregnancy with mifepristone and gemeprost.
    The Australian & New Zealand journal of obstetrics & gynaecology, 1995, Volume: 35, Issue:3

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage

1995
Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected].
    International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2

    Topics: Abortifacient Agents; Adolescent; Adult; Amenorrhea; Chorionic Gonadotropin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hemostatic Techniques; Humans; Incidence; Menstruation-Inducing Agents; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic; Time Factors; Ultrasonography; Uterine Hemorrhage; Uterus

1995
Oral misoprostol versus mifepristone for cervical dilatation before vacuum aspiration in first trimester nulliparous pregnancy: a double blind prospective randomised study.
    British journal of obstetrics and gynaecology, 1996, Volume: 103, Issue:11

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Tablets; Uterine Hemorrhage; Vacuum Extraction, Obstetrical

1996
Early pregnancy termination with mifepristone and misoprostol in the United States.
    The New England journal of medicine, 1998, Apr-30, Volume: 338, Issue:18

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Receptors, Progesterone; Treatment Failure; United States; Uterine Hemorrhage

1998
A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Contraception, 1998, Volume: 58, Issue:2

    Topics: Abortifacient Agents; Abortion, Induced; Adult; Blood Cell Count; Contraceptives, Oral, Combined; Female; Humans; Menstrual Cycle; Methotrexate; Mifepristone; Pessaries; Pregnancy; Prostaglandins; Uterine Hemorrhage

1998
Blood loss with mifepristone--misoprostol abortion: measures from a trial in China, Cuba and India.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1998, Volume: 63, Issue:1

    Topics: Abortifacient Agents; Abortion, Therapeutic; Adult; Blood Loss, Surgical; Cuba; Feasibility Studies; Female; Humans; India; Logistic Models; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Software; Uterine Hemorrhage

1998
A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol.
    Human reproduction (Oxford, England), 1999, Volume: 14, Issue:3

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Missed; Adult; Contraceptives, Oral; Double-Blind Method; Female; Hemoglobins; Humans; Mifepristone; Misoprostol; Placebos; Pregnancy; Time Factors; Uterine Hemorrhage

1999
[Clinical and experimental studies on qumotang for bleeding after medical abortion in 214 cases].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1997, Volume: 17, Issue:9

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Animals; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Pregnancy; Rabbits; Uterine Contraction; Uterine Hemorrhage

1997
Interruption of early pregnancy with mifepristone in combination with gemeprost.
    Acta obstetricia et gynecologica Scandinavica, 1999, Volume: 78, Issue:9

    Topics: Abdominal Pain; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Time Factors; Treatment Outcome; Uterine Hemorrhage

1999
Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration.
    Journal of the American Medical Women's Association (1972), 2000, Volume: 55, Issue:3 Suppl

    Topics: Abortion, Induced; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Uterine Hemorrhage; Vacuum Curettage; Vacuum Extraction, Obstetrical

2000
Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel.
    Human reproduction (Oxford, England), 2000, Volume: 15, Issue:9

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Implants; Female; Hormone Antagonists; Humans; Levonorgestrel; Mifepristone; Placebos; Progesterone; Time Factors; Uterine Hemorrhage

2000
Timing of pain and bleeding after mifepristone-induced abortion.
    Contraception, 2000, Volume: 62, Issue:6

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Administration Schedule; Dysmenorrhea; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Statistics, Nonparametric; Time Factors; Uterine Hemorrhage

2000
[Low doses of mifepristone for emergency contraception].
    Zhonghua fu chan ke za zhi, 1999, Volume: 34, Issue:6

    Topics: Adolescent; Adult; Contraception; Contraceptives, Postcoital, Synthetic; Female; Follow-Up Studies; Humans; Middle Aged; Mifepristone; Nausea; Uterine Hemorrhage

1999
The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial.
    Human reproduction (Oxford, England), 2002, Volume: 17, Issue:1

    Topics: Abortifacient Agents; Abortion, Induced; Adult; Contraceptives, Oral; Female; Hemoglobins; Humans; Mifepristone; Misoprostol; Placebos; Pregnancy; Uterine Hemorrhage

2002
[Prevent from bleeding after medical abortion through prolonged application of mifepristone with misoprostol for terminating early pregnancy].
    Zhonghua fu chan ke za zhi, 2000, Volume: 35, Issue:9

    Topics: Abortion, Induced; Female; Humans; Menstruation; Mifepristone; Misoprostol; Time Factors; Uterine Hemorrhage

2000
Administration of an antiprogesterone up-regulates estrogen receptors in the endometrium of women using Norplant: a pilot study.
    Fertility and sterility, 2002, Volume: 77, Issue:2

    Topics: Biopsy; Contraceptives, Oral, Synthetic; Drug Interactions; Endometrium; Female; Hormone Antagonists; Humans; Immunohistochemistry; Levonorgestrel; Mifepristone; Pilot Projects; Progesterone; Prospective Studies; Receptors, Estrogen; Receptors, Progesterone; Single-Blind Method; Statistics, Nonparametric; Up-Regulation; Uterine Hemorrhage

2002
RU486 combined with PG analogs in voluntary termination of pregnancy.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1991, Volume: 7, Issue:4

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Prostaglandins, Synthetic; Uterine Hemorrhage

1991
Emergency contragestion.
    Contraception, 1987, Volume: 36 Suppl

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Estrenes; Female; Humans; Menstruation-Inducing Agents; Mifepristone; Peptide Fragments; Pregnancy; Progesterone; Uterine Hemorrhage

1987
Early abortion with a single dose of the antiprogestin RU-486.
    American journal of obstetrics and gynecology, 1988, Volume: 158, Issue:6 Pt 1

    Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Clinical Trials as Topic; Estrenes; Female; Humans; Menstrual Cycle; Mifepristone; Peptide Fragments; Pregnancy; Tablets; Time Factors; Uterine Hemorrhage

1988
Pregnancy termination with a high and medium dosage regimen of RU 486.
    Contraception, 1986, Volume: 33, Issue:5

    Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Drug Evaluation; Estrenes; Female; Humans; Hydrocortisone; Mifepristone; Pregnancy; Receptors, Progesterone; Uterine Hemorrhage; Vomiting

1986

Other Studies

38 other study(ies) available for mifepristone and Hemorrhage, Uterine

ArticleYear
Bleeding pattern after medical management of early pregnancy loss with mifepristone-misoprostol and its prognostic value: a prospective observational cohort study.
    Archives of gynecology and obstetrics, 2022, Volume: 306, Issue:2

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prognosis; Prospective Studies; Uterine Hemorrhage

2022
Efficacy of Qiancao () and Haipiaoxiao (), a traditional Chinese herb pair, on abnormal uterine bleeding in rats with incomplete abortion.
    Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2022, Volume: 42, Issue:5

    Topics: Abortion, Incomplete; Abortion, Induced; Animals; China; Female; Humans; Mifepristone; Pregnancy; Rats; Uterine Hemorrhage

2022
[Simultaneous determination and pharmacokinetic study of five compounds from total extract of Clinopodium chinense in abnormal uterine bleeding rat plasma by UPLC-MS/MS].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2022, Volume: 47, Issue:18

    Topics: Administration, Oral; Animals; Apigenin; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drugs, Chinese Herbal; Female; Flavonoids; Hesperidin; Lamiaceae; Mifepristone; Misoprostol; Oleanolic Acid; Plant Extracts; Rats; Saponins; Tandem Mass Spectrometry; Uterine Hemorrhage

2022
Combination of medical and surgical management in successful treatment of caesarean scar pregnancy: a case report series.
    BMC pregnancy and childbirth, 2020, Oct-13, Volume: 20, Issue:1

    Topics: Abortion, Induced; Adult; Cesarean Section; Cicatrix; Combined Modality Therapy; Curettage; Female; Fertility Preservation; Humans; Methotrexate; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Prospective Studies; Treatment Outcome; Ultrasonography, Doppler, Color; Uterine Artery Embolization; Uterine Hemorrhage; Uterus; Young Adult

2020
Taking Call.
    The American journal of nursing, 2021, 05-01, Volume: 121, Issue:5

    Topics: Abortion, Induced; Dysmenorrhea; Female; Humans; Mifepristone; Telemedicine; Uterine Hemorrhage

2021
Medical abortions performed by specialists in private practice.
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2018, 05-29, Volume: 138, Issue:9

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Norway; Pain; Parity; Patient Safety; Patient Satisfaction; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Private Practice; Self Administration; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult

2018
Medical management of first trimester missed miscarriage: the efficacy and complication rate.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019, Volume: 39, Issue:5

    Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Adolescent; Adult; Chorionic Gonadotropin, beta Subunit, Human; Curettage; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Uterine Hemorrhage; Young Adult

2019
Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.
    PloS one, 2013, Volume: 8, Issue:5

    Topics: Abortion, Induced; Adult; Angiopoietin-2; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Uterine Hemorrhage; Young Adult

2013
Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.
    Acta obstetricia et gynecologica Scandinavica, 2014, Volume: 93, Issue:7

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Drug Therapy, Combination; Female; Gestational Age; Health Services Accessibility; Humans; Mifepristone; Misoprostol; Odds Ratio; Pain; Patient Acceptance of Health Care; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; Travel; Uterine Hemorrhage

2014
[Medical termination of pregnancy by mifepristone and misoprostol - evaluation of succes rate, complications and satisfaction of patients].
    Ceska gynekologie, 2015, Volume: 80, Issue:6

    Topics: Abortifacient Agents; Abortion, Induced; Adult; Cohort Studies; Dilatation and Curettage; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Nausea; Personal Satisfaction; Pregnancy; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome; Uterine Hemorrhage; Vomiting

2015
Abnormal expression of MMP-9 and imbalance of MMP-9/TIMP-1 is associated with prolonged uterine bleeding after a medical abortion with mifepristone and misoprostol.
    Acta obstetricia et gynecologica Scandinavica, 2009, Volume: 88, Issue:6

    Topics: Abortifacient Agents; Abortion, Induced; Adult; Cross-Sectional Studies; Female; Humans; Matrix Metalloproteinase 9; Mifepristone; Misoprostol; Pregnancy; Tissue Inhibitor of Metalloproteinase-1; Uterine Hemorrhage

2009
Outcomes of medical abortion through 63 days in women with twin gestations.
    Contraception, 2011, Volume: 84, Issue:5

    Topics: Abortifacient Agents; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adult; Female; Humans; Mifepristone; Misoprostol; Pain Measurement; Postoperative Complications; Pregnancy; Pregnancy, Multiple; Randomized Controlled Trials as Topic; Treatment Outcome; Twins; Uterine Hemorrhage

2011
Effects of leonurine hydrochloride on medically induced incomplete abortion in early pregnancy rats.
    European journal of obstetrics, gynecology, and reproductive biology, 2011, Volume: 159, Issue:2

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Animals; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Estradiol; Female; Gallic Acid; In Vitro Techniques; Mifepristone; Misoprostol; Organ Size; Pregnancy; Random Allocation; Rats; Rats, Sprague-Dawley; Uterine Contraction; Uterine Hemorrhage; Uterus

2011
Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy.
    Contraception, 2011, Volume: 84, Issue:6

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; China; Cohort Studies; Curettage; Female; Follow-Up Studies; Humans; Mifepristone; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, First; Pregnancy Trimester, Second; Prospective Studies; Risk; Surveys and Questionnaires; Uterine Hemorrhage; Young Adult

2011
The Th1/Th2/Th17/Treg paradigm induced by stachydrine hydrochloride reduces uterine bleeding in RU486-induced abortion mice.
    Journal of ethnopharmacology, 2013, Jan-09, Volume: 145, Issue:1

    Topics: Abortion, Induced; Animals; Cytokines; Dose-Response Relationship, Drug; Female; Mice; Mice, Inbred BALB C; Mifepristone; Molecular Targeted Therapy; Pregnancy; Progesterone; Proline; Spleen; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Transcription Factors; Uterine Hemorrhage

2013
Mifepristone-induced vaginal bleeding is associated with increased immunostaining for cyclooxygenase-2 and decrease in prostaglandin dehydrogenase in luteal phase endometrium.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:11

    Topics: Adult; Cyclooxygenase 2; Endometrium; Female; Hormone Antagonists; Humans; Hydroxyprostaglandin Dehydrogenases; Isoenzymes; Kinetics; Luteal Phase; Luteinizing Hormone; Membrane Proteins; Mifepristone; Progesterone; Prostaglandin-Endoperoxide Synthases; Uterine Hemorrhage

2002
[Effect of total glycoside from Clinopodium polycephalum on uterine bleeding quantity in drug abortion model rats].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2002, Volume: 25, Issue:5

    Topics: Abortion, Induced; Animals; Drugs, Chinese Herbal; Female; Glycosides; Hemostatics; Lamiaceae; Male; Mifepristone; Misoprostol; Phytotherapy; Plants, Medicinal; Pregnancy; Rats; Rats, Wistar; Uterine Hemorrhage

2002
Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States.
    Contraception, 2003, Volume: 67, Issue:6

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Anti-Bacterial Agents; Blood Transfusion; Female; Gestational Age; Humans; Hypersensitivity; Infections; Mifepristone; Misoprostol; Pregnancy; United States; Uterine Hemorrhage; Vacuum Curettage

2003
[Effect of Qinggong Zhixue Granule on low immunity mice].
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2004, Volume: 2, Issue:3

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Drugs, Chinese Herbal; Female; Hemolysin Proteins; Mice; Mifepristone; Plant Preparations; Pregnancy; Random Allocation; Uterine Hemorrhage

2004
Frequently asked questions about medical abortion.
    Contraception, 2006, Volume: 74, Issue:1

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Consensus Development Conferences as Topic; Contraception; Counseling; Female; Gestational Age; Health Personnel; Humans; Italy; Mifepristone; Pregnancy; Prostaglandins; Uterine Hemorrhage

2006
[Histopathology appearance of intrauterine residue after medical abortion by mifepristone and prostaglandin analogue].
    Zhonghua fu chan ke za zhi, 1994, Volume: 29, Issue:12

    Topics: Abortion, Induced; Carboprost; Dilatation and Curettage; Drug Synergism; Endometrium; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage

1994
RU486 combined with PGE1 analog in voluntary termination of early pregnancy--a comparison of recent findings with gemeprost or misoprostol.
    Contraception, 1994, Volume: 50, Issue:1

    Topics: Abortion, Induced; Adult; Alprostadil; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage

1994
Vaginal misoprostol administered at home after mifepristone (RU486) for abortion.
    The Journal of family practice, 1997, Volume: 44, Issue:4

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Adolescent; Adult; Female; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Self Administration; United States; Uterine Hemorrhage

1997
Treating colporrhagia after medical abortion with modified shenghua tang.
    Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 1996, Volume: 16, Issue:4

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Animals; Blood Viscosity; Drugs, Chinese Herbal; Female; Humans; Mifepristone; Pregnancy; Rabbits; Uterine Hemorrhage

1996
Unsuccessful treatment of missed abortion.
    British journal of obstetrics and gynaecology, 1998, Volume: 105, Issue:5

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Missed; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy; Uterine Hemorrhage

1998
Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Lancet (London, England), 1998, Aug-15, Volume: 352, Issue:9127

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Analgesics; Diarrhea; Female; Follow-Up Studies; Gestational Age; Humans; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage; Vomiting

1998
[Study of histopathology of endometrium following termination of early pregnancy using mifepristone].
    Zhonghua fu chan ke za zhi, 1999, Volume: 34, Issue:5

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Endometrium; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Uterine Hemorrhage

1999
Medical management of early fetal demise using a combination of mifepristone and misoprostol.
    Human reproduction (Oxford, England), 2001, Volume: 16, Issue:9

    Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adult; Curettage; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fetal Death; Humans; Mifepristone; Misoprostol; Pregnancy; Uterine Hemorrhage

2001
"Inducing a miscarriage": women-centered perspectives on RU 486/prostaglandin as an early abortion method.
    Law, medicine & health care : a publication of the American Society of Law & Medicine, 1992,Fall, Volume: 20, Issue:3

    Topics: Abortion, Induced; Ambulatory Care Facilities; England; Female; France; Humans; Internationality; Mifepristone; Multicenter Studies as Topic; Paternalism; Personal Autonomy; Pregnancy; Pregnant Women; Prostaglandins E, Synthetic; Risk Assessment; Time Factors; Uterine Hemorrhage; Vacuum Curettage

1992
The effects of RU-38486 on cervical ripening. Clinical studies.
    American journal of obstetrics and gynecology, 1990, Volume: 162, Issue:1

    Topics: Abortion, Induced; Adult; Cervix Uteri; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Random Allocation; Uterine Hemorrhage

1990
Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience.
    The New England journal of medicine, 1990, Mar-08, Volume: 322, Issue:10

    Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Drug Evaluation; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage

1990
RU 486.
    Scientific American, 1990, Volume: 262, Issue:6

    Topics: Abortion, Induced; Animals; Developing Countries; Endometrium; Female; France; Humans; Mifepristone; Models, Molecular; Molecular Structure; Population Control; Pregnancy; Progesterone; Prostaglandins; Rabbits; Receptors, Glucocorticoid; Receptors, Progesterone; Uterine Hemorrhage; Uterus

1990
Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost).
    Contraception, 1989, Volume: 40, Issue:4

    Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Therapeutic; Alprostadil; Drug Therapy, Combination; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Premedication; Uterine Hemorrhage

1989
[Experiences with the antigestagen mifepristone (RU 486) in the interruption of early pregnancy].
    Zentralblatt fur Gynakologie, 1989, Volume: 111, Issue:19

    Topics: Abortion, Induced; Adult; Drug Administration Schedule; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Pregnancy, Unwanted; Uterine Hemorrhage

1989
Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Clinical endocrinology, 1989, Volume: 31, Issue:1

    Topics: Adult; Chorionic Gonadotropin; Drug Interactions; Endometrium; Estradiol; Female; Humans; Luteal Phase; Luteinizing Hormone; Mifepristone; Progesterone; Tamoxifen; Uterine Hemorrhage

1989
The safety of early abortion.
    The Practitioner, 1989, Nov-22, Volume: 233, Issue:1479

    Topics: Abortion, Induced; Accident Prevention; Female; Humans; Mifepristone; Pregnancy; Safety; Time Factors; Uterine Hemorrhage

1989
[Early pregnancy interruption using an antiprogesterone steroid: Mifepristone (RU 486)].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1988, Volume: 17, Issue:8

    Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Adult; Dose-Response Relationship, Drug; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Progestins; Uterine Hemorrhage

1988
Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone).
    The New England journal of medicine, 1986, Dec-18, Volume: 315, Issue:25

    Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Chorionic Gonadotropin; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Uterine Hemorrhage

1986